These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33101986)

  • 1. Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance.
    Kreile M; Lubina O; Ozola-Zalite I; Lugovska R; Pronina N; Sterna O; Vevere P; Konika M; Malniece I; Gailite L
    Mol Genet Metab Rep; 2020 Dec; 25():100671. PubMed ID: 33101986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need.
    Brooks DL; Whittaker MN; Qu P; Musunuru K; Ahrens-Nicklas RC; Wang X
    Am J Hum Genet; 2023 Dec; 110(12):2003-2014. PubMed ID: 37924808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of phenylketonuria in Latvia.
    Pronina N; Giannattasio S; Lattanzio P; Lugovska R; Vevere P; Kornejeva A
    Hum Mutat; 2003 Apr; 21(4):398-9. PubMed ID: 12655551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untreated PKU patients without intellectual disability:
    Klaassen K; Djordjevic M; Skakic A; Kecman B; Drmanac R; Pavlovic S; Stojiljkovic M
    Mol Genet Metab Rep; 2021 Dec; 29():100822. PubMed ID: 34900593
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Iuhas A; Jurca C; Kozma K; Riza AL; Streață I; Petcheși C; Dan A; Sava C; Balmoș A; Marinău C; Niulaș L; Ioana M; Bembea M
    Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population.
    Eisensmith RC; Martinez DR; Kuzmin AI; Goltsov AA; Brown A; Singh R; Elsas LJ II; Woo SL
    Pediatrics; 1996 Apr; 97(4):512-6. PubMed ID: 8632937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study.
    Rajabi F; Rohr F; Wessel A; Martell L; Dobrowolski SF; Guldberg P; Güttler F; Levy HL
    Mol Genet Metab; 2019 Dec; 128(4):415-421. PubMed ID: 31623983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman.
    Alghamdi MA; O'Donnell-Luria A; Almontashiri NA; AlAali WY; Ali HH; Levy HL
    JIMD Rep; 2023 Sep; 64(5):312-316. PubMed ID: 37701331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis.
    Zimmermann M; Jacobs P; Fingerhut R; Torresani T; Thöny B; Blau N; Baumgartner MR; Rohrbach M
    Mol Genet Metab; 2012 Jul; 106(3):264-8. PubMed ID: 22607939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKU and COVID19: How the pandemic changed metabolic control.
    Rovelli V; Zuvadelli J; Ercoli V; Montanari C; Paci S; Dionigi AR; Scopari A; Salvatici E; Cefalo G; Banderali G
    Mol Genet Metab Rep; 2021 Jun; 27():100759. PubMed ID: 33907667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylketonuria: an inborn error of phenylalanine metabolism.
    Williams RA; Mamotte CD; Burnett JR
    Clin Biochem Rev; 2008 Feb; 29(1):31-41. PubMed ID: 18566668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice.
    Cacicedo ML; Weinl-Tenbruck C; Frank D; Limeres MJ; Wirsching S; Hilbert K; Pasha Famian MA; Horscroft N; Hennermann JB; Zepp F; Chevessier-Tünnesen F; Gehring S
    Front Bioeng Biotechnol; 2022; 10():993298. PubMed ID: 36277393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genetic Landscape and Epidemiology of Phenylketonuria.
    Hillert A; Anikster Y; Belanger-Quintana A; Burlina A; Burton BK; Carducci C; Chiesa AE; Christodoulou J; Đorđević M; Desviat LR; Eliyahu A; Evers RAF; Fajkusova L; Feillet F; Bonfim-Freitas PE; Giżewska M; Gundorova P; Karall D; Kneller K; Kutsev SI; Leuzzi V; Levy HL; Lichter-Konecki U; Muntau AC; Namour F; Oltarzewski M; Paras A; Perez B; Polak E; Polyakov AV; Porta F; Rohrbach M; Scholl-Bürgi S; Spécola N; Stojiljković M; Shen N; Santana-da Silva LC; Skouma A; van Spronsen F; Stoppioni V; Thöny B; Trefz FK; Vockley J; Yu Y; Zschocke J; Hoffmann GF; Garbade SF; Blau N
    Am J Hum Genet; 2020 Aug; 107(2):234-250. PubMed ID: 32668217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
    Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
    Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Work activity and phenylalanine levels in a population of young adults with classic PKU.
    Riva MA; Madotto F; Turato M; Salvatici E; Indovina S; Giovannini M; Riva E; Cesana G
    Med Lav; 2017 Apr; 108(2):118-122. PubMed ID: 28446738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.